- Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype
-
Han DH, Moh IH, Kim DM, Ihm SH, Choi MG, Yoo HJ, Hong EG
- KMID: 1780111
- Korean J Intern Med.
- 2013 Sep;28(5):609-613.
- doi: 10.3904/kjim.2013.28.5.609
We report the case of a patient who experienced extreme recurrent gestational hyperlipidemia. She was diagnosed with partial lipoprotein lipase (LPL) deficiency but without an associated LPL gene mutation in... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic predisposition in nonalcoholic fatty liver disease
-
Sookoian S, Pirola CJ
- KMID: 2412107
- Clin Mol Hepatol.
- 2017 Mar;23(1):1-12.
- doi: 10.3350/cmh.2016.0109
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has reached global epidemic proportions. Although the disease is relatively benign in the early stages, when... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model
-
Moon MH, Jeong JK, Lee JH, Park YG, Lee YJ, Seol JW, Park SY
- KMID: 1506224
- Exp Mol Med.
- 2012 Oct;44(10):603-614.
Higher levels of body fat are associated with an increased risk for development numerous adverse health conditions. FTY720 is an immune modulator and a synthetic analogue of sphingosine 1-phosphate (S1P),... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic Fatty Liver Disease
-
Ko JS
- KMID: 1775872
- Korean J Gastroenterol.
- 2010 Jul;56(1):6-14.
- doi: 10.4166/kjg.2010.56.1.6
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, and is commonly associated with obesity. The spectrum of NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH)... -
- CITED
-
- Close
- SHARE
-
- Close
